Journal of Parkinsons Disease

作者需在提交过程中列出每位作者的贡献，并在提交稿件的致谢部分之后加入“作者贡献”标题，该信息将在校对阶段显示于该标题下。 模型中文摘要

You will be asked to list the contribution of each author as part of the submission process. Please include the Author Contributions heading within your submission after the Acknowledgements section. The information you give on submission will then show under the Author Contributions heading later at the proofing stage.

期刊致力于促进研究的开放、透明和可重复性，鼓励作者在符合伦理和法律要求的前提下，将研究数据存入相关公共数据仓库、提供链接数据的数据可用性声明（如无法共享则说明原因）并在研究中引用该数据。 模型中文摘要

The Journal is committed to facilitating openness, transparency and reproducibility of research, and has the following research data sharing policy. For more information, including FAQs please visit the Sage Research Data policy pages. Subject to appropriate ethical and legal considerations, authors are encouraged to: Share your research data in a relevant public data repository Include a data ava…

作者须在指定标题下提供伦理批准声明，即使方法部分已包含相关信息；若无需伦理批准也须明确说明；涉及人类参与者、人类数据或人体组织的研究须注明伦理委员会或机构审查委员会的批准或豁免，并提供委员会全称、所属机构及批准号。 模型中文摘要

Please include your ethics approval statements under this heading, even if you have already included ethics approval information in your methods section. If ethical approval was not required, you need to explicitly state this. All papers reporting studies involving human participants, human data or human tissue must state that the relevant Ethics Committee or Institutional Review Board approved th…

《帕金森病杂志》为开放获取、同行评审期刊，所有被接受的文章在出版后立即免费在线发布，采用知识共享许可并永久在线保存；稿件经同行评审被接受后须支付一次性文章处理费（APC）3200美元，由资助方、机构或作者承担，提交稿件本身不收费。 模型中文摘要

Journal of Parkinson’s Disease is an open access, peer-reviewed journal. All accepted articles are made freely available online immediately upon publication, are published under a Creative Commons license, and hosted online in perpetuity. If, after peer review, your manuscript is accepted for publication, a one-time article processing charge (APC) is payable to cover the cost of publishing, paid b…

该期刊采用单盲同行评审，审稿人与编辑互动，不公布评审信息；稿件先经初步评估，不符合要求的稿件将被退回修改，超出范围或不合适的稿件可能未经同行评审即被拒稿，通过初评后进入同行评审。 模型中文摘要

The following summary describes the peer review process for this journal: Identity transparency: Single-anonymized Reviewer interacts with: Editor Review information published: None Your manuscript will undergo an initial evaluation. If it does not conform to the requirements laid out in these guidelines, it will be returned to you for amendments prior to peer review. Manuscripts may be desk rejec…

期刊和Sage严肃对待版权侵犯、抄袭及其他违反出版最佳实践的行为，并请作者阅读Sage完整的抄袭政策及可能采取的措施。 模型中文摘要

The journal and Sage take issues of copyright infringement, plagiarism or other breaches of best practice in publication very seriously. Please read Sage's complete policy on plagiarism and the actions we may take.

期刊接受已在预印本服务器上发布的稿件，提交时须在指定字段填写预印本DOI，建议在提交时告知期刊编辑部，且同行评审期间不应在预印本服务器上发布更新版本。 模型中文摘要

The journal will consider submissions of manuscripts that have been posted on preprint servers. Please enter the preprint DOI in the designated field when submitting your manuscript. We advise that you inform the Journal Editorial office about your posted preprint at submission. Note that you should not post an updated version of your manuscript on a preprint server while it is being peer reviewed…

期刊认可ICMJE要求，临床试验须在首个受试者入组时或之前在WHO认可的公共试验注册机构注册；与AllTrials运动一致，如延迟注册的理由可接受，回顾性注册的试验也将被考虑；试验注册机构名称、网址及注册号必须列在摘要末尾。 模型中文摘要

The journal endorses the ICMJE requirement that clinical trials are registered in a WHO-approved public trials registry at or before the time of first participant enrollment. However, consistent with the AllTrials campaign, retrospectively registered trials will be considered if the justification for late registration is acceptable. The trial registry name and URL, and registration number must be …